2Gilman S, Low PA, Quinn N,et al. Consensus statement on the diagnosis of multiple system atrophy[J].J Neurol Sci,1999,163(1):94-98.
3Osaki Y, Wenning GK, Daniel SE, et al. Do published criteria improve clinical diagnostic accuracy in multiple system atrophy?[J].Neurology,2002,59(10):1486-1491.
4Ben-Shlomo Y, Wenning GK, Tison F, et al. Survival of patients with pathologically proven multiple system atrophy: a meta-analysis[J].Neurology,1997,48(2):384-393.
5Wenning GK, Tison F, Ben Shlomo Y, et al. Multiple system atrophy: a review of 203 pathologically proven cases[J].Mov Disord,1997,12(2):133-147.
6Horimoto Y, Aiba I, Yasuda T, et al. Longitudinal MRI study of multiple system atrophy :when do the findings appear, and what is the course?[J].J Neurol,2002,249(7):847-854.
7Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy Drager syndrome)[J].J Neurol Sci,1989,94(1-3):79-100.
8Shibuya K, Nagatomo H, Iwabuchi K,et al. Asymmetrical temporal lobe atrophy with massive neuronal inclusions in multiple system atrophy[J].J Neurol Sci,2000,179(S 1-2):50.
9Spillantini MG, Crowther RA, Jakes R, et al. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies[J].Neurosci Lett,1998,251(3):205-208.
6Mitsui Y,Tanaka H. Nakamura Y,et al. Neuroradiological findings of sporadic olivopontocerebeliar atrophy with marked laterality and degenerative changes in the corticopontine tract. Rinsho-Shinkeigaku ,1996.36(10):1150.
7Perani D,Bressi S ,Testa D ,et al. Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F18 position emission tomographic study. Arch-Neurol,1995,52(2):179.
8Yamaguchi S, Fukuyama H, Ogawa M,et al. Olivopontocerebellar atrophy studied by position emission tomography and magnetic resonance imaging. J Neurol Sci, 1994,125(1):56.
